- Display 15 Products per page
Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing
Published: July 1, 2004 | Price: $3,500.00 – $7,000.00
After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies are searching for business solutions to streamline operations and cut costs as they strive to continue generating above-average shareholder returns. Outsourcing has become an integral, ongoing element of pharmaceutical companies’ business...
Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition
Published: May 1, 2009 | Price: $1,500.00 – $9,000.00
Kalorama Information's 300 page Worldwide Wound Care: Total Market Coverage report represents the full contents of the Kalorama three-volume 2009 wound care series. The reports are joined in one volume to offer a better value to the customer that wants total market coverage. Kalorama's approach differs from other published reports in that we segment the world wound care market by application: skin ulcers, burns and surgical/trauma wounds. Wound care is a vast market and this approach ensures that customers can...
Successful Commercialization Strategies for New Healthcare Products and Technologies
Published: June 1, 2003 | Price: $995.00 – $2,992.00
According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting cancer and other diseases earlier when they are more treatable are moving from dream to reality. It is obvious that even if all of these drugs and devices make it to...
Lateral Flow Technology And The Future Of Point Of Care Diagnostics, 2nd Edition
Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...
The World Market for Personalized Medicine Tests for Cancer
Published: January 19, 2017 | Price: $2,396.00 – $4,800.00
The World Market for Personalized Medicine Tests for Cancer This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)
The World Market for Molecular Diagnostics Tests, 11th Edition
Published: November 3, 2022 | Price: $6,000.00 – $12,000.00
Kalorama Information’s 11th Edition report of the clinical molecular testing industry provides marketing sizing and forecasts for in vitro diagnostics (IVDs) over a five-year period. In this report, our industry experts and top analysts assess the current positions of this complex market, which has an estimated value of more than $21 billion. This data publication has become an indispensable tool in clinical healthcare medicine and assesses the business opportunity, new product introductions, and rapid changes in several areas of this...
The Market and Future Potential for Molecular Point of Care
Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)
Published: January 1, 2016 | Price: $2,396.00 – $4,792.00
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others) In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing...
Direct-to-Consumer Pharmaceutical Marketing 2005: Controversies Continue
Published: April 1, 2005 | Price: $1,995.00 – $3,990.00
This timely overview of direct to consumer (DTC) pharmaceutical marketing examines the numerous issues surrounding DTC practices and markets, using industry and consumer publications as well as interviews with industry experts. The topics examined include: DTC marketing spending by product, DTC marketing spending by company DTC marketing spending by media channel The ROI debate on the cost-effectiveness of DTC marketing expenditures Arguments for and against DTC marketing by its proponents and critics DTC marketing regulations in the U.S. and selected...
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, Cancer Point of Care, Rapid Coagulation, Urine Testing, Lipids, Pregnancy, Glucose and Other Tests)
Published: March 17, 2020 | Price: $5,500.00 – $11,000.00
This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...
In Vitro Toxicology Market
Published: July 19, 2018 | Price: $4,500.00 – $9,000.00
In Vitro Toxicology In Vitro Toxicology analyses global in vitro toxicity testing markets and various market segments with the objective to identify the important market trends that will bring further growth in this market. The study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for various toxicity endpoint segments for 2018-2023, including ADME-Tox; cytotoxicity; genotoxicity;...
Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)
Published: February 1, 2009 | Price: $1,500.00 – $7,000.00
The reinvigorated market for medical imaging systems employing x-rays has undoubtedly been propelled by the explosion of digital technology. But also, the expanded role of imaging modalities in a whole host of clinical applications from trauma to cancer to cardiology has increased the profile of radiography while enabling computer technologies expand the usefulness of traditional x-ray techniques. Kalorama's Medical Imaging Markets Volume I: Radiography analyzes the current and potential world market for medical x-ray systems, including several distinct imaging modalities...
Physician Office In Vitro Diagnostic (IVD) Test Markets
Published: January 9, 2023 | Price: $5,000.00 – $10,000.00
This report analyzes trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories. Specific products consist of reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies. Physicians’ office laboratories are defined as point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. Most of these laboratories implement IVD procedures through one or more portable desktop instruments...
Pharmaceutical Markets in Russia
Published: January 1, 2009 | Price: $995.00 – $1,990.00
The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets. For the...
Point of Care (POC) Infectious Disease Diagnostic Testing Market
Published: March 22, 2018 | Price: $2,995.00 – $5,995.00
This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players. As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...